Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Sequana Medical

Request full access

Developing implantable and drug-based solutions to treat fluid overload in advanced liver and heart disease

Ghent, BelgiumFounded 2006Health Tech & Medtech

About Sequana Medical

Sequana Medical is a medical technology company that develops implantable and drug-based treatments for fluid overload in patients with liver disease, heart failure, and certain cancers. The company focuses on addressing cases where standard diuretic therapies are no longer effective.

The company’s main product, the alfapump®, is an implantable device that automatically transfers excess fluid from the abdominal cavity (ascites) to the bladder, where it is naturally excreted by the body. This system is designed for patients with liver disease who experience recurrent fluid build-up, helping to reduce the need for repeated hospital visits and manual fluid removal procedures.

Sequana Medical is also developing Direct Sodium Removal (DSR®) therapy, a drug-based method that aims to reduce fluid overload by removing sodium from the body. This approach is being studied primarily for patients with heart failure who are resistant to conventional diuretic treatments.

With ongoing clinical studies and regulatory development, Sequana Medical is working to expand access to its technologies and provide new options for patients with limited treatment alternatives.

Source: Dealroom company data

At a glance

Status
Listed
Founded
2006
Headquarters
Ghent, Belgium
Listing
IPO 2019
Employees
62
Open positions
None listed
Dealroom signal
85.1/100
Industry
Health
Sub-industry
Medical Devices
Sector
Health Tech & Medtech, Oncology, Cardiology and cardiovascular
Business model
Manufacturing
Client focus
B2B

Funding history

10 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
POST IPO EQUITY✓Other financing Apr 2025 $0 — Global Emerging Markets ↗
POST IPO CONVERTIBLE✓Other financing Mar 2025 $6.9M — SFPIM ↗
Showing the latest 2 of 10 recorded eventsBook a demo for the full funding history →

Financials

Revenue, earnings and profit over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

YearRevenueGrowthEBITDAMarginProfitMargin
2026 $116K 0% −$45M -38978.3% −$49M -42325.7%
2025 $116K 0% −$45M -38978.3% −$49M -42325.7%
2024 $116K -85.2% −$45M -38978.3% −$49M -42325.7%
2023 $783K -22.8% −$32M -4134.7%
2022 $1M +149% −$31M -3042.8%
2021 $408K -61.5% −$24M -6002.9%
2020 $1.1M — −$19M -1823.7%
Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

Sequana Medical website traffic

Latest recorded traffic for Sequana Medical is 8.4K monthly website visits, up 127% over the last three months. Sequana Medical's team grew 5.1% over the past year.

Latest monthly visits8.4K 3-month web change+127% 1-year team growth+5.1%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Sequana Medical in the Ghent ecosystem

Live from Dealroom

The Sequana Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

16 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A7 investors entered at this stage

  • Entrepreneurs Fund
  • BioMedVC
  • Capricorn Partners
  • Rosetta Capital
  • Partners in Equity (PiE)
  • Sensinnovat
  • EQT Group

Series B and later8 investors entered at this stage

  • EQT Life Sciences
  • VI Partners
  • NeoMed
  • PMV
  • Newton BioCapital
  • SFPIM
  • Kreos Capital
  • Global Emerging Markets

Other known investors1 additional known investor

  • Bootstrap Europe
Team profiled 21 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
6 countries with
team presence
🇨🇭 Switzerland62.5%
🇧🇪 Belgium15%
🇺🇸 United States12.5%
🇬🇧 United Kingdom5%
🇨🇦 Canada2.5%
Top 5 of 6 shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Sequana Medical on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Sequana Medical’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.